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ABSTRACT 
Objective: The main objective of this study was to develop and evaluate the eudragit and HPMC coated metformin hydrochloride floating 
microspheres, in which HPMC helps in floating and eudragit as a coating material for a site-specific drug release in a controlled manner and the 
active moiety metformin used as anti-hyperglycemic agent.  
Methods: The floating microsphere was prepared by the solvent evaporation method incorporating metformin as a model drug. The prepared 
floating microsphere were characterized for particle size, %yield, drug loading and entrapment efficiency, compatibility study, %buoyancy, surface 
morphology and In vitro drug release and release kinetics. 
Results: The result metformin loaded floating microsphere was successfully prepared and the particle size range from 397±23.22 to 595±15.82 µm, 
the entrapment efficiency range from 83.49±1.33 to 60.02±1.65% and drug loading capacity range from 14.3±0.54 to 13.31±0.47% and %buoyancy 
range from 85.67±0.58 to 80.67±1.15%. The FT-IR and X-RD analysis confirmed that no any interaction between drug and excipient, and surface 
morphology confirmed those particles are sphere. The floating microsphere show maximum 96% drug release in pH 0.1N HCL and follow the 
Korsmeyer peppas model of the super case-2 transport mechanism. 
Conclusion: These results suggest that metformin loaded floating microspheres could be retain in stomach for long time and give site specific drug 
release in controlled manner.  
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INTRODUCTION 
Most preferred route for drug delivery is the oral route due to its 
patient compliance and easiness of ingestion and cost-effectiveness. 
Many different techniques have been developed like tablet capsule 
syrups etc for delivery of a significant amount of drug at a specific 
site and time prearranged and systematic manner but this route has 
numerous physiological problems, like-easily bypass through GIT at 
major absorption zone (stomach and upper part of intestine) due to 
high density and low density retention time resulting incomplete 
drug release and low efficacy of drug unpredictable absorption due 
to degradation of drug by stomach acid and enzyme [1], hence the 
site specific drug delivery for diabetic through oral route is also most 
challenging task for researchers. So these difficulties provoked the 
investigators to develop a DDS known as gastro retentive floating 
microspheres which performs its actions i.e. its therapeutically 
active plasma concentration of drug for prolonged period of time, by 
minimizing the dosing criteria and minimizing the fluctuations in 
plasma concentration of drug by the pharmacological effect of the 
drug in a systemic and controlled way. After oral delivery of gastro 
retentive floating microspheres, the drug reserved in to the stomach 
and performs the action of drug release in a well-ordered manner, so 
that the delivery of drug is continuous at its absorption sites in GIT 
(gastrointestinal tract) [2]. The floating systems are low-density 
systems that have sufficient buoyancy to float over the gastric 
content and remain buoyant the stomach without affecting the 
gastric emptying rate for a prolonged period of time which causes 
the inadequate release of drug at the absorption site [3]. Over the 
last minority decades, several gastro-retentive drug delivery 
systems being intended, including high-density systems that is 
retain in the lower part of the stomach [4], lower density which 
cause buoyancy in gastric-juice [5, 6], mucoadhesive systems that 
cause a bio-adhesion to stomach mucosa [7, 8], unfoldable, 
extendible, or swellable systems which can restriction of the 
emptying dosage forms through the pyloric sphincter [9, 10], super-
porous hydrogel system [11], magnetic system, etc [12]. Here we are 
developing lower density system that’s floating microsphere, is 
prepared by solvent evaporation method incorporating metformin 
as a model drug. The active moiety metformin is an anti-
hyperglycemic agent that’s fast soluble in stomach pH so the drug 
immediately released and not remains to specific site for long time. 
To overcome these problems, we prepare eudragit coated, HPMC 
and metformin hydrochloride loaded floating microspheres [13]. 
The HPMC helps in floating that helps in long-time retention of 
microspheres into stomach and eudragit as a coating material to 
prevent the fast solubility of metformin hydrochloride in acidic pH 
and give site specific drug release in a controlled manner. Then 
metformin hydrochloride easily reduce the production from hepatic 
and glucose absorption from the intestine, and improved sensitivity 
of insulin by increasing tangential uptake of glucose and its 
utilization. In this process Metformin decreases blood glucose levels. 
The recent study describes the various Gastro-retentive approaches 
which are newly developed into leading methodologies in the field of 
site-specific orally controlled release drug delivery systems. 
MATERIALS AND METHODS 
Metformin hydrochloride was a gift sample from the Sun 
Pharmaceutical Industries Ltd., Vadodara, India. HPMC was 
procured from the LOBA Cheme Pvt. Ltd., Mumbai and the 
eudragitS100 was procured from the Central Drug House Pvt. Ltd., 
New Delhi. All the chemicals and solvent used in the study were of 
analytical grade. 
Preparation of floating microspheres  
Floating microspheres were prepared by emulsification (o/w) 
solvent evaporation method using a varying concentration of 
polymers (HPMC, Eudragit S100). The polymer solution was 
prepared by dissolving polymers (HPMC, EudragitS100) in different 
ratio of the mixture of solvents (ethanol, dichloromethane) with 
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vigorous shaking. The aqueous solution containing tween80 was 
taken in another beaker. The polymer solution was then added 
manually dropwise into the aqueous solution through a syringe 
(needle size 22 gauges) under continuous stirring at 100 rpm. The 
added droplets were kept dispersed in the aqueous solution for 30 
min. to complete the reaction and to produce spherical rigid 
microspheres. The formed microspheres were collected and washed 
with distilled water 2-3 times and air-dried for 24 h [14, 15]. The 
drug-loaded microspheres shown in fig. 1 were prepared by the 
solvent evaporation method according to the above-described 
method by varying concentration of polymers (HPMC, eudragit) and 
drug. The compositions of floating microsphere are given in table 1. 
  











Aqueous phase containing 1% Tween 80 
(ml) 
01 Formulation-1 400 100 20 0 150 
02 Formulation-2 500 100 20 0 150 
03 Formulation-3 600 100 20 0 150 
04 Formulation-4 700 100 20 0 150 
05 Formulation-5 800 100 20 0 150 
06 Formulation-6 600 100 20 100 150 
07 Formulation-7 700 100 20 100 150 
08 Formulation-8 700 100 20 150 150 
09 Formulation-9 700 100 20 175 150 
10 Formulation10 700 100 20 200 150 
 
 
Fig. 1: Preparation of floating microspheres 
 
Particle size 
Particle size of the blank and metformin hydrochloride loaded 
microsphere was determined by optical microscopy method using a 
compound microscope (Olympus India) equipped with ocular and 
calibrated stage micrometers. After the calibration of an ocular 
micrometer by placing the ocular lens after that the focusing on the 
object to be measured and determine the size in ocular units, then 
placing the samples on the slide and measuring the size of microspheres 
[16]. 





The percentage yield of the blank and metformin hydrochloride 
microspheres preparation was obtained by applying the mentioned 
formula [17]. 




Percentage buoyancy  
The percentage buoyancy of the microspheres was calculated by the 
500 mg of the microspheres place in a USP mentioned type ІІ 
instrument filled with 900 ml of 0.1 NHCL which consists of tween 
80 with stirring for 12 h at 50 rpm. After 12 h the particles of 
floating nature and the precipitated particles are taken out and dried 







Where-wf= Weight of floating particles, ws= Weight of settled 
particles 
Determination of drug content of microspheres  
The 50 mg microspheres were dissolved in few ml of ethanol and 
dilute with 50 ml of 0.1N hydrochloric acid in a 100 ml volumetric 
flask and mixture was shaken until a formulation was destructed. 
The solution was passed through W. F. P (No. 41). Then diluted with 
ethanol and evaluated by UV-VIS spectrophotometer (233λmax) 
using a UV-1800 Shimadzu spectrophotometer. 




Drug entrapment efficiency 
Entrapment efficiency of microspheres was determined by 
extraction of drug from the microspheres. In a typical procedure, 50 
mg of dried microsphere were crushed in a mortar and pestle, and 
the fine microspheres dissolved in few ml of Ethanol and dilute with 
50 ml of 0.1N HCL for 24h. After 24h, the solution was passed 
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through a 0.45μm filter and the conc. of the metformin 
hydrochloride present in the filtrate was evaluated 
spectrophotometrically at 233 nm using UV-Visible 
Spectrophotometer (Shimadzu, UV-1800, Japan) with respect to 0.1N 
HCL as blank [19]. 
Drug entrapment efficiency = 
Weight of drud in microspheres
Weight of the fed drug
×100 
Micromeritic properties of microspheres 
Prepared microspheres were evaluated for their micrometric 
properties such as as bulk density, tapped density, compressibility 
index, and angle of repose. 
• Bulk density 
Bulk density of microspheres was evaluated by the ratio of the 
untapped microsphere weight and its volume it’s obtained by this 
formula [20]. 




Where M = Weight of microsphere sample, V ° = Apparent volume of 
the microsphere 
• Tapped density 
The tapped density was calculated by mechanical tapping of a 
graduated measuring cylinder which consists of the microspheres. It 
is the ratio of the initial microsphere volume with tapped volume of 
microsphere (after tapping) [21]. 
Tapped density = 
Weight of microspheres
Final tapped volume of the microspheres
 
• Compressibility index 
The compressibility index is a tendency of microspheres to be 





Where-TD = Tapped Density, BD = Bulk Density 
• Angle of repose 
This property was evaluated by the maximum angle possible 
between the surface of the pile of the microspheres and the 
horizontal plane; it’s obtained by the funnel in a fixed position. 
θ = tan-1(h/r) 
Drug polymer compatibility study 
Drug-polymer interaction studies were carried out by using FT-IR 
and XRD analysis. 
• FTIR study 
The FT-IR study of blank and drug-loaded formulations was 
performed to find any possible drug-polymer interaction using 
Fourier Transform Infra-red spectrometer (Bruker Alpha, Germany) 
in the frequency range of 4000-400 cm-1 [22].  
• XRD analysis 
The effect of crystallinity of drug and excipient on formulation was 
evaluated by using XRD analysis. The XRD patterns of blank and 
drug-loaded microspheres were recorded using X-ray 
Diffractometer (Rigaku-Ultima IV, Japan), using Cu radiation, a 
voltage of 40 kV and a current of 30 mA. The scanning speed 
employed was 2 °/min over the range of 10 ° to 90° diffraction angle 
[23]. 
Morphological characterization 
The shape and size of the metformin hydrochloride-loaded 
microsphere were assessed by SEM. The samples were prepared by 
mounting the sample onto a metal stub with adhesive tape on both 
sides. Carbon coating was done in a high vacuum evaporator. Then 
the process of scanning and taking images was done [24]. 
In vitro drug release study 
The In vitro drug release studies were performed by USP dissolution 
Test Apparatus Type 1 (Basket Type) at 100 rpm in 900 ml of 
dissolution medium and at a temperature of 37 °C±0.5 °C. An 
accurately weighed amount of prepared microspheres (equivalent to 
100 mg) were used for the study. The test performed in 0.1N HCl as 
dissolution media. After a time interval of 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
12 and 24 h, 5 ml of sample was withdrawn from dissolution media 
and replaced by 5 ml of the fresh medium. The sample was passed 
through W. F. P. and assayed spectrophotometrically at 233 nm using a 
UV-Visible spectrophotometer (Shimadzu, UV-1800, Japan) [25, 26]. 
In vitro drug release kinetics 
To investigate the drug release mechanism from the microspheres, 
in vitro drug release data was fitted to various kinetic models like 
zero order, first order, Higuchi equation, and Korsmeyer-Peppas 
equation. By comparing the r values obtained, the best fit model was 
selected [27-30]. 
• Zero-order kinetics 
Dissolution of the drug from the dosage forms that do not 
disaggregate and release the drug slowly can be represented by the 
following equation. 
Qt = Q0+K0t 
Where, Qt is the amount of drug dissolved in time t, Q0 is the 
Initial amount of drug in the solution and K0 is the zero-order 
release rate constant. To study the release kinetics, data 
obtained from the in vitro drug release studies were plotted as % 
CDR vs. Time. 
• First-order kinetics 
This model has been used to describe the absorption or elimination 
of drugs. The release of the drug which followed first-order kinetics 





Where C is the amount of drug release in time t, C0 is the amount 
of drug in the solution and K is the first-order release rate 
constant. To study the release kinetic data obtained from the in 
vitro drug release studies were plotted as log % drug unreleased 
vs. Time. 
• Higuchi model 
This model used to describe the release of water-soluble and low 
water-soluble drugs from the solid or semisolid matrix system. 
Mathematical expressions were obtained for drug particles 
dispersed in uniform matrix behaving as the diffusion media. The 
mathematical expression of Higuchi model is as follows:  
Qt = KH. t1/2 
Whereas Qt is the amount of drug release in time t and KH is the 
Higuchi dissolution constant. To study the release kinetics, data 
obtained from the in vitro drug release were plotted as % CDR vs 
Square root of time. 
• Korsmeyer-peppas model 
This model used to describe the release of drugs from the polymeric 
system when the release mechanism is not well known or more than 
one type of release phenomena could be involved. The equation of 
the Korsmeyer-Peppas model is as follows:  

∞




 is the fraction of drug release, K is the release rate 
constant, t is the release time and n is the release exponent 
To study the release kinetics, data obtained from the in vitro drug 
release were plotted log % CDR vs. Time. Peppas used this n-value in 
order to characterize different release mechanisms as given in table 2. 
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Table 2: Different release mechanism 
Diffusion release exponent (n) Overall drug diffusion mechanism Time-dependence of drug release rate (dMt/dt) 
0.5 Fickian diffusion t- °.5 
0.45<n = 0.89 Non-Fickian diffusion tn-1 
0.89 Case II transport Zero order (time independent) release 
Higher than 0.89 Super case II transport tn-t 
 
RESULTS AND DISCUSSION 
The metformin loaded lower density microsphere were prepared by 
emulsification (o/w) solvent evaporation method according to the 
above-described method by varying concentration of polymers 
(HPMC, eudragit) and metformin. 
Characterization of floating microspheres 
% Yield and particle size 
The particle size of the optimized formulation was determined by the 
optical microscopy. The % yield and particle size of the formulations 
found to be b/w 70.5 to 86.8% and 397.73 to 628.27 µm. The 
microspheres formulation F1, F2 was not formed completely only 
some particles appeared in solution. After filtration, the clumps of the 
microsphere adhere on the filter paper and not rigid and stable. It was 
due to less concentration of HPMC. As the concentration of HPMC 
increased in formulation F3 and F4 the microspheres were formed 
with good yield and particle size values of F3 (72.9%, 397.73 µm) and 
F4 (81.1% 415.47 µm) respectively. On further increasing the HPMC 
concentration in formulation F5, the yield was found to be decreased 
but particle size was increase. Due to softness and aggregation of the 
microsphere with each other and adhere on filter paper again due to 
the high concentration of HPMC. Finally F3 and F4 blank microsphere 
which ratio HPMC: Eudragit (7:1) were appropriate for rigid and 
stable microsphere so here F3 and F4 blank microsphere selected to 
be loaded with metformin hydrochloride in formulation F6 to F10. On 
loading with 100 mg drug, F7 was found to have a better yield than F6 
but the particle size increase with drug concentration. On further 
increasing the drug amount to 150 mg in F8 the % yield was found to 
be increased. But afterward, the % yield was found to be constant with 
increasing in the drug amount due to saturation of formulation. 
According to Patel B. et al., they also justified that increases the 
polymer concentrations then increase the % yield as well as particle 
size up to a level [31]. The maximum % yield was found to be of 
formulation F8 as results shown in table 3. 
% Buoyancy of the formulation 
The % buoyancy depends on the density of HPMC and eudragit and 
drug in stomach contents 0.1 N HCL. The density of excipient and 
drug was less hence microspheres float on 0.1 N HCL. The % 
buoyancy of formulation F3 to F9 was found to be b/w 72.33 to 
87.67%. The % buoyancy of blank F3 and F4 was high as compare to 
other formulation due to the less concentration of both excipients. 
And when gradually increase the concentration of HPMC with drug 
the % buoyancy decrease. Formulation F7 and F8 were found to 
have % buoyancy of 81.33 to 80.67%, respectively that was good as 
compared to other drug loaded formulation. The % buoyancy proves 
that the microsphere float in the stomach for a long time and worked 
as a gastro retentive drug delivery reservoirs [32]. The % buoyancy 
shows in the table 3. 
 
Table 3: %Yield, particle size and buoyancy of drug loaded microspheres 
Formulation % Yield Particle size (µm) % Buoyancy 
F3 72.9±0.56 397.73±23.22 85.67±0.58 
F4 81.1±0.86 415.47±19.13 87.67±0.58 
F5 70.5±0.65 628.27±30.72 72.33±1.53 
F6 75.0±0.80 438.72±24.43 77.67±0.58 
F7 84.4±0.66 476.27±11.61 81.33±1.53 
F8 86.8±0.66 526.93±11.61 80.67±1.15 
F9 79.2±1.21 567.47±24.43 75.33±0.58 
F10 82.2±1.06 595.33±15.82 69.67±1.53 
Data are presented as mean±SD (n = 3) 
 
Drug loading and drug entrapment 
The % Drug loading and % entrapment efficiency of the formulation 
were found to be b/w 11.10 to17.04% and 60.02 to 95.30% 
respectively. Out of the five drug-loaded formulations (F6-F10), the 
formulation F8 was found to have a maximum % drug loading 
(17.04%) and maximum % entrapment efficiency (95.30%). The % 
drug loading and % entrapment efficiency were found to be 
decreased with an increase in the amount of drug to be loaded 
beyond 150 mg (F8) i.e. F9, F10 due to the saturation of the 
microspheres with the drug [33, 34]. The Drug loading and 
entrapment efficacy of formulations were determined by the direct 
extraction method and the results are shown in table 4.  
Micromeritic properties 
All the micrometric properties were found in an acceptable range. The 
compressibility index of the formulations (F6, F7, F8, and F10) was 
found range between (7.04 to 20.00 %) have excellent flow-ability and 
the formulation F9, found to have fair flow-ability. The angle of repose 
of all the formulations range from (18.147 to 27.47%) showed 
excellent flow property [35]. The results are shown in table 4. 
 
Table 4: Drug loading, entrapment efficiency and micromeritic properties of drug-loaded microspheres 






Compressibility index Angle of repose 
(ɵ) 
F6 14.30±0.54 83.49±1.33 0.75±0.01 0.86±0.01 12.79 18.15 
F7 11.10±0.75 87.43±1.97 0.73±0.04 0.84±0.01 13.10 24.26 
F8 17.04±0.43 95.30±0.49 0.66±0.02 0.71±0.02 7.04 21.80 
F9 15.58±0.62 68.43±1.29 0.76±0.01 0.95±0.02 20.00 27.47 
10 13.31±0.47 60.02±1.65 0.71±0.03 0.81±0.01 12.35 25.91 
Data are presented as mean±SD (n = 3) 
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Optimization of formulation 
The formulation F8 was optimized based on % yield, buoyancy, % 
drug loading, % entrapment efficiency and micrometric properties 
because formulation F8 shows the good % yield (86.8%), % buoyancy 
(80.67%), % drug loading (17.04%), % entrapment efficiency 
(95.30%) as compare to other formulation. Further studies i.e. FTIR 
study, SEM, X-RD and drug release were performed on the optimized 
formulation (F8) that was finally optimized by the above parameters. 
Drug polymer compatibility study 
FTIR study 
FT-IR spectra were recorded to assess the compatibility of the pure 
drug with other excipients present in the formulation. The FT-IR 
spectrum of optimized microspheres formulation F8 was recorded 
separately and compared with the spectrum of pure drug, HPMC, 
eudragit, blank formulation to verify the possible interaction 
between the constituent and the characteristic peaks. The main peak 
of Metformin hydrochloride bands was N-H(stretching)-3365.04 cm-
1, N-(CH3)2-3140.87 cm-1, C-N-930.38 cm-1and N-H(bending)-1622.37 
cm-1 was present in drug spectra but absent in the blank formulation 
because drug was absent in blank, and drug-loaded microspheres 
exhibited all the characteristics of absorption bands as that of drug 
metformin hydrochloride without any prominent changes and the 
FT-IR spectra shows that the drug has not gone through any kind of 
interactions with the excipient as well as formulation [36]. The FTIR 
spectra of drug and other excipient shown in fig. 2. 
X-RD study 
The effect of the crystallinity of the optimized formulation was 
recorded by using an X-ray diffractometer. From the study, it was 
observed that Metformin hydrochloride showed sharp crystalline 
peaks clearly visible at the position between 15-18 ° (2θ) shown in 
fig.3 which shows the crystalline nature of the drug. The polymer 
gave the broad spectrum peak that showed the amorphous nature of 
the polymer. The diffract gram of the metformin-loaded microsphere 
formulation (F8) showed diminished intensities of peak indicating 
that the drug was molecularly disbursed in the polymeric matrix or 
might have undergone amorphization during the preparation of the 
microspheres. The compatibility study confirmed that Metformin 
hydrochloride was compatible with other excipient and doesn’t get 
al. tered during formulation of microsphere, was the show in fig. 3. 
  
 




Fig. 3: X-RD of HPMC, eudragit, metformin hydrochloride, blank floating microspheres and optimized drug-loaded microspheres (F8) 
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SEM (scanning electron microscopy) 
The shape and surface characteristics of metformin-loaded 
microsphere optimized formulation (F8) were determined by 
scanning electron microscope (SEM). The shape of the microsphere 
was found spherical with a rough surface and the microspheres 
were solid without any porous on the surface. The agglomeration of 
microspheres was not seen because of the rigid nature of 
microspheres [37]. The SEM photograph of microspheres is shown 
in fig. 4. 
 
 
Fig. 4: SEM of the metformin hydrochloride loaded microspheres 
 
In vitro drug release study 
The in vitro drug release study demonstrated that metformin-loaded 
microsphere optimized formulation (F8) showed maximum drug 
release (96.48%) in the gastric pH 0.1N HCl up to 24 h and the 
sample was analyzed in triplicate. The in vitro study of optimized 
formulations (F8) was performed by using USP Dissolution Test 
Apparatus Type 1 (Basket Type) in the 0.1N HCl. The drug release 
profile of optimized formulation (F8) was release the drug in a 
controlled manner for a long time that shows the formulation F8 was 
work as a controlled drug delivery system and give high 
bioavailability [38]. The result of the release study is shown in fig. 5. 
 
 
Fig. 5: Drug release graph of optimized formulation (F8) data points represented mean±SD (n=3) 
 
In vitro drug release kinetics 
The data obtained from in vitro release study were fitted to various 
kinetic equations to find out the mechanism of drug release from the 
optimized drug loaded formulation (F8). The kinetic models used were 
a zero-order equation, first-order equation, Higuchi model and 
Korsmeyer-Peppas model. Drug release kinetics was best fitted to the 
Korsmeyer-peppas model as the R2 value for the model was 0.971 
which was very closer to 1, than the other R2 value of other models. 
The drug release mechanism was of Super case II transport as the 
release exponent, the drug get the release from the microsphere by 
erosion system, the ‘n’ value was found to be 1.490 which was greater 
than 1. The graphical representation of different kinetic models of in 
vitro drug release profile is shown in fig. 6 to 9 and table 5. 
 
Table 5: Release kinetics of optimized formulation F8 
Formulation code Zero order First order Higuchi model Korsmeyer-peppas 
(R2) value (R2) value (R2) value (R2) value 
F-8 0.879 0.953 0.903 0.971 
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Fig. 6: Zero-order kinetics of optimized formulation (F8) 
 
 
Fig. 7: First order kinetics of optimized formulation (F8) 
 
 
Fig. 8: Korsmeyer-peppas model of optimized formulation (F8) 
 
 
Fig. 9: Higuchi model of optimized formulation (F8) 
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CONCLUSION 
The HPMC and eudragit S100 blend microspheres loaded with 
metformin hydrochloride were formulated successfully by using a 
modified solvent evaporation method and optimized the F8 
formulation by different parameters like % yield, buoyancy, % drug 
loading, % entrapment efficiency and micrometric properties. The % 
yield, % buoyancy, % drug loading and % entrapment efficiency was 
found to be of optimized formulation F8 84.4%, 80.67%, 17.04% and 
95.30% respectively. The % yield was decreased with increasing the 
drug concentration and the % buoyancy was affected by changing the 
ratio of polymer and drug. The % drug loading and % entrapment 
efficiency decreased with an increase in the amount of drug to be 
loaded beyond 150 mg i.e. F9, F10 due to saturation of the 
microspheres with the drug. The FTIR spectrum of optimized 
formulation F8 showed that there was no chemical interaction and 
drug was compatible with polymer. The sharp peak of Metformin 
hydrochloride was also appearing in optimized formulation F8, which 
revealed the drug incorporate into the microspheres. The SEM study of 
formulation F8 with nearly spherical shape and a rough surface 
without any pore. The formulation F8 release the 96% drug in 24 h 
that shows the formulation F8 was work as a controlled drug delivery 
system. Drug release kinetics of F8 formulation was best fitted for the 
Korsmeyer-peppas model and the drug release mechanism was of 
super case-2 transport. In which drug release by erosion mechanism. 
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